Skip to main content
. 2021 Feb 4;180(2):313–324. doi: 10.1093/toxsci/kfab011

Figure 2.

Figure 2.

The cat-1 (ok411) strain is deficient in the production of cat-1/VMAT protein. A, Primers specific for cat-1 reveal a 400 bp deletion in the cat-1 (ok411) mutant strain. B, The strain cat-1 (ok411) does not produce cat-1/VMAT protein. C, The cat-1(ok411) strain (B) shows no evidence of cat-1/VMAT immunoreactivity (detail of pharyngeal region).